Spots Global Cancer Trial Database for medullary thyroid carcinoma
Every month we try and update this database with for medullary thyroid carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer | NCT04211337 | Medullary Thyro... | Selpercatinib Cabozantinib Vandetanib | 12 Years - | Eli Lilly and Company | |
| ImmunoTEP for Patients With Medullary Thyroid Carcinoma. | NCT01730638 | Medullary Thyro... | • TF2 and 68 Ga... | 18 Years - | Nantes University Hospital | |
| Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma | NCT01736878 | Medullary Thyro... | Sorafenib | 18 Years - | Eanm Research Ltd | |
| 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors | NCT01373736 | Pheochromocytom... Neuroblastoma Paraganglioma Medullary Thyro... Carcinoid Tumor... | 123I-meta-iodob... | - | Vancouver Coastal Health | |
| Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma | NCT01661179 | Unresectable Lo... | Vandetanib 300m... | 20 Years - | Sanofi | |
| Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients | NCT01424878 | Medullary Thyro... Multiple Endocr... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
| A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) | NCT04787328 | Medullary Thyro... | HA121-28 tablet... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma | NCT01661179 | Unresectable Lo... | Vandetanib 300m... | 20 Years - | Sanofi | |
| 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer | NCT03647657 | Thyroid Cancer,... | 177Lu-PP-F11N Sacuitril | 18 Years - 64 Years | University Hospital, Basel, Switzerland | |
| ImmunoTEP for Patients With Medullary Thyroid Carcinoma. | NCT01730638 | Medullary Thyro... | • TF2 and 68 Ga... | 18 Years - | Nantes University Hospital | |
| 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer | NCT03647657 | Thyroid Cancer,... | 177Lu-PP-F11N Sacuitril | 18 Years - 64 Years | University Hospital, Basel, Switzerland | |
| A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation | NCT04280081 | Solid Tumor Medullary Thyro... | Selpercatinib | 18 Years - | Eli Lilly and Company | |
| 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. | NCT02088645 | Thyroid Cancer,... Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... | 177Lu-PP-F11N | 18 Years - | University Hospital, Basel, Switzerland | |
| Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma | NCT03636945 | Medullary Thyro... | PET at 18F-FDOP... | 18 Years - | Assistance Publique Hopitaux De Marseille | |
| A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) | NCT00923247 | Medullary Thyro... | Bortezomib Vandetanib | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma. | NCT06067594 | Medullary Thyro... Nodular Goiter | Fine Needle Asp... | 18 Years - | Austral University, Argentina | |
| 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors | NCT01373736 | Pheochromocytom... Neuroblastoma Paraganglioma Medullary Thyro... Carcinoid Tumor... | 123I-meta-iodob... | - | Vancouver Coastal Health | |
| Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer | NCT00514046 | Medullary Thyro... Multiple Endocr... Multiple Endocr... | Vandetanib | 5 Years - 18 Years | National Institutes of Health Clinical Center (CC) | |
| An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) | NCT01511393 | Diabetes Diabetes Mellit... Medullary Thyro... Weight Manageme... | No treatment gi... | 18 Years - | Novo Nordisk A/S | |
| ImmunoTEP for Patients With Medullary Thyroid Carcinoma. | NCT01730638 | Medullary Thyro... | • TF2 and 68 Ga... | 18 Years - | Nantes University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
